Abstract
Investigators from 7 centers in Korea conducted a prospective, multicenter study with patients randomized into two open-label, parallel groups and treated with either levetiracetam (LVT) or carbamazepine (CBZ) monotherapy for newly diagnosed focal epilepsy.
DOI: https://doi.org/10.15844/pedneurbriefs-29-7-2 | Journal eISSN: 2166-6482
Language: English
Page range: 51 - 51
Submitted on: Jul 21, 2015
Accepted on: Jul 28, 2015
Published on: Jul 31, 2015
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 2015 Lindsey Morgan, Alexandra Shaw, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.